USPTO serial 97977375
METRIX
Reviewed by CopyMark Law Group
- Filing date
- Status date
- Registration date
- Jul 14, 2026
- Examiner
- HESIK, APRIL ANNE
- Law office
- PUBLICATION AND ISSUE SECTION
What this means
Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six. Calendar Section 8 between years five and six, and consider trademark monitoring.
Need help with METRIX?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Enshan Hong
Enshan Hong MAGSTONE LAW, LLP1180 AVENUE OF THE AMERICAS, 8TH FLOORNEW YORK, NY 10036United StatesGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 009 | Downloadable or recorded software, namely, sample preparation and analysis software for clinical research and medical uses; sample preparation device for clinical research use in the nature of a disposable sample collector component acting as a tube, and an optional disposable sample swab, sponge or wand to facilitate the collection of saliva, urine, blood, sputum, feces, semen, and other bodily fluids and tissues, or other biological samples that are easy to obtain by contacting an affected area, such as throat, nasal, nasopharyngeal, vaginal, and superficial wound cultures; sample analysis devices, namely, a cartridge that analyzes biological samples for clinical research use; kits comprised of sample collection devices and sample preparation devices for clinical research use in the nature of a cartridge, a disposable sample collector component acting as a tube, and an optional disposable sample swab, sponge or wand to facilitate the collection of saliva, urine, blood, sputum, feces, semen, other bodily fluids and tissues, or other biological samples that are easy to obtain by contacting an affected area, such as throat, nasal, nasopharyngeal, vaginal, and superficial wound cultures; analyte detection systems for clinical research use, comprising downloadable or recorded sample preparation and analysis software and sample preparation and analysis devices, namely, cartridges and sample collectors, sold as a unit; an analyte detection system for clinical research use, comprising downloadable or recorded sample preparation and analysis software, sample collection device, a sample preparation device, a sample analysis device, namely, cartridges and sample collectors, sold as a unit; downloadable or recorded software for health diagnostic testing device for identifying the presence, absence, and/or quantity of particular nucleic acids, proteins, organism, or other analytes of interest, for example, in order to test for the presence of one or more pathogens or contaminants in a sample; downloadable computer application software for mobile phones and handheld computers for use by patients for recording, logging, tracking, analyzing, and reviewing medical conditions, symptoms, ailments and asymptomatic conditions; downloadable computer application software for mobile phones and handheld computers for use by patients for viewing informational videos and accessing information in connection with recorded medical conditions, symptoms, ailments and asymptomatic conditions; downloadable computer software for mobile phones and handheld computers for use by patients for viewing historically recorded medical conditions, symptoms, ailments and asymptomatic conditions; downloadable computer application software for mobile phones and handheld computers for use by patients for receiving and reviewing medical messages and notifications from medical service providers; wireless communication devices for wireless transmission of medical data and information; downloadable computer software for use by healthcare professionals in registering patients, accessing patient information, entering and viewing patient data and records, analyzing and interpreting patient medical information, managing patient profiles, processing billing, reviewing healthcare insurance information, obtaining customer support services, tracking medical devices used by patients, and managing medical device and supply inventory | ACTIVE | Jun 1, 2026 |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by Aptitude Medical Systems Inc.
- Other trademarks owned by Aptitude Medical Systems Inc.
- Other trademarks owned by Aptitude Medical Systems Inc.
- Other trademarks in Class 009
- Similar marks named METRIX
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Jul 14, 2026 | NRCC | NOTICE OF REGISTRATION CONFIRMATION EMAILED | — |
| Jul 14, 2026 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Jun 25, 2026 | SUNA | NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED | — |
| Jun 25, 2026 | CNPR | ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED | — |
| Jun 9, 2026 | SUPC | STATEMENT OF USE PROCESSING COMPLETE | — |
| Jun 2, 2026 | IUAF | USE AMENDMENT FILED | — |
| Jun 2, 2026 | EISU | TEAS STATEMENT OF USE RECEIVED | The applicant filed a Statement of Use with specimens showing the mark in actual commerce. The USPTO will review the filing for compliance. If accepted, the mark can proceed to registration; if deficient, the USPTO may issue a requirement or office action. |
| Feb 13, 2026 | EXRA | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | — |
| Feb 12, 2026 | EX5G | SOU EXTENSION 5 GRANTED | — |
| Dec 9, 2025 | EXRA | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | — |
| Dec 8, 2025 | EEXT | SOU TEAS EXTENSION RECEIVED | The applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use. |
| Dec 8, 2025 | EX4G | SOU EXTENSION 4 GRANTED | — |
| Dec 7, 2025 | EXT5 | SOU EXTENSION 5 FILED | — |
| Oct 22, 2025 | NREV | NOTICE OF REVIVAL - E-MAILED | — |
| Oct 22, 2025 | TPEX | SOU EXTENSION RECEIVED WITH TEAS PETITION | — |
| Oct 22, 2025 | PETG | PETITION TO REVIVE-GRANTED | — |
| Oct 22, 2025 | PROA | TEAS PETITION TO REVIVE RECEIVED | — |
| Oct 16, 2025 | MAB6 | ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED | The intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window. |
| Oct 16, 2025 | ABN6 | ABANDONMENT - NO USE STATEMENT FILED | The intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window. |
| Jun 6, 2025 | EXT4 | SOU EXTENSION 4 FILED | — |
| Oct 11, 2024 | EXRA | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | — |
| Oct 11, 2024 | EX3G | SOU EXTENSION 3 GRANTED | — |
| Oct 11, 2024 | EXT3 | SOU EXTENSION 3 FILED | — |
| Oct 11, 2024 | EEXT | SOU TEAS EXTENSION RECEIVED | The applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use. |
| Aug 2, 2024 | EXRA | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | — |
| Aug 2, 2024 | EX2G | SOU EXTENSION 2 GRANTED | — |
| Jul 11, 2024 | NREV | NOTICE OF REVIVAL - E-MAILED | — |
| Jul 11, 2024 | TPEX | SOU EXTENSION RECEIVED WITH TEAS PETITION | — |
| Jul 11, 2024 | PETG | PETITION TO REVIVE-GRANTED | — |
| Jul 11, 2024 | PROA | TEAS PETITION TO REVIVE RECEIVED | — |
| Jul 8, 2024 | ABN6 | ABANDONMENT - NO USE STATEMENT FILED | The intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window. |
| Jun 6, 2024 | EXT2 | SOU EXTENSION 2 FILED | — |
| Apr 17, 2024 | EXRA | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | — |
| Apr 16, 2024 | EX1G | SOU EXTENSION 1 GRANTED | — |
| Apr 16, 2024 | AITU | CASE ASSIGNED TO INTENT TO USE PARALEGAL | — |
| Feb 5, 2024 | NREV | NOTICE OF REVIVAL - E-MAILED | — |
| Feb 5, 2024 | TPEX | SOU EXTENSION RECEIVED WITH TEAS PETITION | — |
| Feb 5, 2024 | PETG | PETITION TO REVIVE-GRANTED | — |
| Feb 5, 2024 | PROA | TEAS PETITION TO REVIVE RECEIVED | — |
| Feb 1, 2024 | MAB6 | ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED | The intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window. |
| Feb 1, 2024 | NOAC | CORRECTED NOA E-MAILED | — |
| Jan 31, 2024 | ABN6 | ABANDONMENT - NO USE STATEMENT FILED | The intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window. |
| Jan 31, 2024 | DPCC | DIVISIONAL PROCESSING COMPLETE | — |
| Jan 30, 2024 | AITU | CASE ASSIGNED TO INTENT TO USE PARALEGAL | — |
| Dec 6, 2023 | EXT1 | SOU EXTENSION 1 FILED | — |
| Oct 30, 2023 | AITU | CASE ASSIGNED TO INTENT TO USE PARALEGAL | — |
| Oct 17, 2023 | DRRR | DIVISIONAL REQUEST RECEIVED | — |
| Oct 17, 2023 | ERTD | TEAS REQUEST TO DIVIDE RECEIVED | — |
| Jun 6, 2023 | NOAM | NOA E-MAILED - SOU REQUIRED FROM APPLICANT | A Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date. |
| Apr 11, 2023 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Apr 11, 2023 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Mar 22, 2023 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Mar 8, 2023 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Mar 8, 2023 | XAEC | EXAMINER'S AMENDMENT ENTERED | — |
| Mar 8, 2023 | GNEN | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | — |
| Mar 8, 2023 | GNEA | EXAMINERS AMENDMENT E-MAILED | — |
| Mar 8, 2023 | CNEA | EXAMINERS AMENDMENT -WRITTEN | — |
| Jan 28, 2023 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Jan 28, 2023 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Jan 28, 2023 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Dec 20, 2022 | GNRN | NOTIFICATION OF NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Dec 20, 2022 | GNRT | NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Dec 20, 2022 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Dec 9, 2022 | DOCK | ASSIGNED TO EXAMINER | — |
| Apr 25, 2022 | AMPX | PRELIMINARY/VOLUNTARY AMENDMENT - ENTERED | — |
| Apr 21, 2022 | ALIE | ASSIGNED TO LIE | — |
| Apr 18, 2022 | PARI | TEAS VOLUNTARY AMENDMENT RECEIVED | — |
| Apr 18, 2022 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Apr 15, 2022 | NWAP | NEW APPLICATION ENTERED | — |